why choose us

First received: March 23, 2023

Clinical Trial: A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Relapsing Forms of Multiple Sclerosis

Study Type: INTERVENTIONAL


Official Title: A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumar

Brief Summary: In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses.It is a 2-part study.In Part 1, one set of participants will take either BIIB091 or diroximel fumarate (DRF).In Part 2, a different set of participants will take either a combination of BIIB091 and DRF or DRF alone.The goal of the study is to learn more about the safety of BIIB091 and to compare the effects of the study drug when taken alone or together with DRF.The main question…

Read more